GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Sale Of Investment

Biomics Biopharma (ASX:BBM) Sale Of Investment : A$ Mil (TTM As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Sale Of Investment?

Biomics Biopharma's sale of investment for the six months ended in . 20 was A$0.00 Mil. It means Biomics Biopharma gained A$0.00 Mil from selling investments.

Compared with last quarter (A$0.00 Mil in . 20 ), Biomics Biopharma gained the same money from selling investments in . 20 (A$0.00 Mil).


Biomics Biopharma Sale Of Investment Historical Data

The historical data trend for Biomics Biopharma's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Sale Of Investment Chart

Biomics Biopharma Annual Data
Trend
Sale Of Investment

Biomics Biopharma Semi-Annual Data
Sale Of Investment

Biomics Biopharma Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.


Biomics Biopharma Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomics Biopharma (ASX:BBM) Business Description

Traded in Other Exchanges
N/A
Address
1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines